Study of Tumor and Blood Samples From Women With Breast Cancer
|ClinicalTrials.gov Identifier: NCT00897728|
Recruitment Status : Unknown
Verified July 2009 by National Cancer Institute (NCI).
Recruitment status was: Recruiting
First Posted : May 12, 2009
Last Update Posted : December 1, 2010
RATIONALE: Studying samples of tumor tissue and blood from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer.
PURPOSE: This research study is looking at tumor and blood samples from women with breast cancer.
|Condition or disease||Intervention/treatment|
|Breast Cancer||Other: laboratory biomarker analysis|
- Assess relapse locally or remotely using biomarkers collected from primary tumor and blood samples from women with breast cancer during the first 2 years after diagnosis.
- Evaluate all relapses.
- Assess survival without relapse.
- Determine correlation between biomarkers and relapse.
OUTLINE: Primary tumor and blood samples collected during usual care of patients during the first 2 years after diagnosis are analyzed for biomarkers useful in monitoring and diagnosing breast cancer.
|Study Type :||Observational|
|Estimated Enrollment :||180 participants|
|Official Title:||Colon and Breast Cancer Diagnostics. Clinical Protocol Associated With Cancer of the Breast.|
|Study Start Date :||February 2008|
|Estimated Primary Completion Date :||February 2010|
- Local or remote relapse as assessed by biomarkers in tissue and blood samples collected during the first 2 years after diagnosis
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00897728
|Institut Curie Hopital||Recruiting|
|Paris, France, 75248|
|Contact: Paul-Henri Cottu 33-3-8393-5005|
|Study Chair:||Paul-Henri Cottu||Institut Curie|